Relapsed Pediatric ALL

Oncology·MeSH: Precursor Cell Lymphoblastic Leukemia-Lymphoma

9 drugs in development·2 companies·2 clinical trials

Drug Pipeline by Phase

Phase 3(6)

Drug	Company
anti-thymocyte globulin	Filana Therapeutics Inc. (FLNA)
horse anti-thymocyte globulin	Filana Therapeutics Inc. (FLNA)
Melphalan	Filana Therapeutics Inc. (FLNA)
Mesna	Filana Therapeutics Inc. (FLNA)
rabbit anti-thymocyte globulin	Filana Therapeutics Inc. (FLNA)
Thiotepa	Filana Therapeutics Inc. (FLNA)

Phase 2(1)

Drug	Company
Filgrastim	Filana Therapeutics Inc. (FLNA)

Phase 1(2)

Drug	Company
Anti-STEAP1 CAR T-cells	Filana Therapeutics Inc. (FLNA)
Mesna	Structure Therapeutics Inc. (GPCR)

BioSniper tracks 9 drugs in development for Relapsed Pediatric ALL across 2 companies.

There are 2 clinical trials targeting Relapsed Pediatric ALL tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.